In vitro, the expression of TGF-β1 was inhibited in a dose-dependent manner, and IFN-γ levels were also upregulated in NIH/3T3, thus alleviating the lung fibrosis induced by LPS (Du et al., 2012). Here, TGFB1 is linked to pulmonary fibrosis.